Clinical trial
The Effects of Growth Hormone (GH) on Lipid Depots
NCT00491582 · Insel Gruppe AG, University Hospital Bern, Other · Completed
Key facts
| NCT number | NCT00491582 |
|---|---|
| Title | The Effects of Growth Hormone (GH) on Lipid Depots |
| Official title | The Effect of Growth Hormone (GH) on Intramyocellular Lipids (IMCL), Intrahepatocellular Lipids (IHCL) and Visceral Fat Mass in Relation to Insulin Resistance |
| Lead sponsor | Insel Gruppe AG, University Hospital Bern, Other |
| Collaborators | Swiss National Science Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | Growth hormone replacement therapy in growth hormone deficient patients only. |
| Enrollment | 34 |
| Start date | Jul 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jun 1, 2013 |
| First posted | Jun 26, 2007 |
| Last update posted | Aug 13, 2013 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: